How to Navigate Menopause & Perimenopause for Maximum Health & Vitality | Dr. Mary Claire Haver

Huberman Lab Podcast Recap

Published:

Duration: 2 hr 18 min

Guests: Dr. Mary Claire Haver

Summary

This episode features Dr. Mary Claire Haver, an expert in perimenopause and menopause, discussing the physiological changes and health implications of these stages. The episode provides insights into the importance of hormone therapy, lifestyle adjustments, and the need for more focused research on...

What Happened

Dr. Mary Claire Haver, a board-certified OB GYN and expert in perimenopause and menopause, provides an in-depth look at the phases leading up to and including menopause, noting that perimenopause can begin 7 to 10 years before the last menstrual period. By the time women reach their 30s, they are down to about 10% of their egg supply, a number that drops to 3% by age 40.

Menopause marks the end of ovarian function, characterized by a significant decline in sex hormone production. The average age of menopause in the US is 51 to 52 years old, but this can vary widely, with African Americans experiencing menopause earlier and Asians later. Dr. Haver emphasizes that menopause symptoms can have a profound economic impact, with 1 in 5 women quitting their jobs due to these issues.

Hormonal changes during perimenopause can lead to a 40% increase in mental health disorders, with a doubling of SSRI use. Hormone therapy during this time has been shown to lower the incidence of new-onset depression. The episode also highlights the problematic definition of menopause for women who don't experience regular periods due to conditions like hysterectomy or the use of an IUD.

Dr. Haver discusses the benefits of healthier lifestyle choices, such as an anti-inflammatory diet and regular exercise, in improving the course of perimenopause. Specific dietary recommendations include increasing fiber intake to 25 grams per day and maintaining a protein intake of 80-120 grams depending on body composition. Resistance training is recommended to combat muscle loss and visceral fat gain during menopause.

Hormone therapy is presented as the gold standard for treating hot flashes and other symptoms, with non-oral forms being preferred to avoid liver processing and potential clotting risks. Dr. Haver notes the misconception from the Women's Health Initiative study that linked estrogen to breast cancer, clarifying that starting hormone therapy between ages 50-59 can reduce cardiovascular disease risk by 50%.

The episode addresses the lack of funding for women's health research, with menopause affecting one-third of a woman's life but only receiving 0.03% of NIH funding. Dr. Haver also points out that many women are offered antidepressants instead of hormone therapy, despite estrogen's neuroprotective benefits and its role in stabilizing mental health during perimenopause.

Key Insights

View all Huberman Lab recaps